CIK 0001708527 · Non-accelerated filer<br>Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474790334
- Phone
- 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-22 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +17,533 | 17,533 | ||
| 2022-12-15 | Colpman David Director | Purchase | +3,098 | $3.90 | $12K | 3,098 |
| 2022-12-09 | Makes Brigid Director | Purchase | +2,000 | $3.65 | $7K | 2,000 |
| 2022-12-08 | Birchview Capital, LP 10% owner | Purchase | +9,061 | $3.79 | $34K | 1,511,184 |
| 2022-12-08 | Birchview Capital, LP 10% owner | Purchase | +4,000 | $3.79 | $15K | 1,515,184 |
| 2022-12-07 | Birchview Capital, LP 10% owner | Purchase | +10,000 | $3.58 | $36K | 1,468,123 |
| 2022-12-07 | Birchview Capital, LP 10% owner | Purchase | +34,000 | $3.58 | $122K | 1,502,123 |
| 2022-12-05 | HighCape Capital, L.P. Director | Purchase | +735,000 | $4.75 | $3.5M | 5,597,604 |
| 2022-12-05 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Purchase | +20,000 | $4.75 | $95K | 43,217 |
| 2022-12-05 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Purchase | +2,000 | $3.61 | $7K | 45,217 |
| 2022-12-02 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Purchase | +6,000 | $4.03 | $24K | 23,217 |
| 2022-12-01 | Birchview Capital, LP 10% owner | Purchase | +40,000 | $4.75 | $190K | 1,458,123 |
| 2022-10-20 | Williams Michelle LeRoux CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2022-10-20 | Colpman David Director | Grant or award · Stock Option (Right to Buy) | +28,513 | 28,513 | ||
| 2022-09-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Option exercise | +13,874 | 22,015 | ||
| 2022-09-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −4,798 | $7.30 | $35K | 17,217 |
| 2022-09-08 | Ferguson Matthew CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −13,874 | 0 | ||
| 2022-09-08 | Edwards Peter G GENERAL COUNSEL | Option exercise | +4,625 | 4,625 | ||
| 2022-09-08 | Edwards Peter G GENERAL COUNSEL | Shares withheld for taxes | −1,127 | $7.30 | $8K | 3,498 |
| 2022-09-08 | Edwards Peter G GENERAL COUNSEL | Option exercise · Restricted Stock Units | −4,625 | 0 |
Page 12 of 17 · 330 trades